Invokana Diabetic Ketoacidosis and Kidney Failure Lawyers

Invokana Diabetic Ketoacidosis and Kidney Failure

Invokana (canagliflozin) was approved in 2013 as a treatment for type 2 diabetes. This drug, made by Janssen Pharmaceuticals, is a member of the SGLT2 inhibitor family, a newer generation of diabetes drugs which are designed to help patients eliminate excess blood sugar through urination. Unfortunately, the fact that these drugs are designed to alter kidney function has led to a high risk of dangerous and potentially Invokana side effects including diabetic ketoacidosis and kidney failure.

We are currently investigating Invokana side effects lawsuits on behalf of patients across the United States who have suffered from diabetic ketoacidosis or kidney failure.

What is Invokana Diabetic Ketoacidosis?

On May 15, 2015 the FDA issued a Drug Safety Communication to warn that SGLT2 inhibitor drugs like Invokana have been associated with a high risk of diabetic ketoacidosis. The U.S. National Library of Medicine states that diabetic ketoacidosis occurs when insufficient insulin makes it impossible for the body to process glucose for energy. Instead, the body must break down fat and muscle tissue for fuel and this creates acidic waste products called ketones, which are poisonous in high levels.

Patients who suffer from diabetic ketoacidosis which is not treated promptly may fall into a diabetic coma, suffer kidney failure or heart attack, or may even die as a result of this potential Invokana side effect. If you or someone you love used Invokana or another SGLT2 inhibitor to control type 2 diabetes, it is imperative that you remain aware of the following symptoms of diabetic ketoacidosis

  • Confusion
  • Weakness or drowsiness
  • Nausea or vomiting
  • Abdominal pain
  • Rapid breathing
  • Dry skin
  • Extreme thirst
  • Frequent urination
  • Fruity smell to the breath
  • Achy or stiff muscles


Invokana Kidney Failure Risk

In addition to diabetic ketoacidosis, Invokana and other SGLT2 inhibitors have also been associated with kidney failure. The way SGLT2 inhibitors help patients with type 2 diabetes maintain safe blood sugar levels is by preventing a membrane in the kidneys from allowing sugar filtered by the kidneys to return into a patient’s bloodstream. Instead, this sugar is expelled through urination. In short, the goal of Invokana is to inhibit normal kidney function.

According to a 2015 report from the Institute of Safe Medication Practices (ISMP), many of the 457 adverse events reported in Invokana patients in the first year this drug was available suggested kidney problems or even kidney failure. At least 54 of the cases reported were confirmed to be kidney impairment or kidney failure.

Invokana Side Effects Lawsuit Consultations

In Invokana side effects, individuals who have suffered injury or the loss of a loved one due to diabetic ketoacidosis or kidney failure are claiming that Janssen Pharmaceuticals failed to provide fair warning of these potentially fatal risks. If you have suffered due to diabetic ketoacidosis, kidney failure, or another SGLT2 inhibitor side effect, you could be due substantial compensation or your physical, emotional, and financial damages. Please contact us today to learn more in a free Invokana side effects lawsuit consultation.